Cargando…

Novel therapies are changing treatment paradigms in metastatic prostate cancer

Metastatic castration-resistant prostate cancer (mCRPC) remains a terminal diagnosis with an aggressive disease course despite currently approved therapeutics. The recent successful development of poly ADP-ribose polymerase (PARP) inhibitors for patients with mCRPC and mutations in DNA damage repair...

Descripción completa

Detalles Bibliográficos
Autores principales:	Powers, Eric, Karachaliou, Georgia Sofia, Kao, Chester, Harrison, Michael R., Hoimes, Christopher J., George, Daniel J., Armstrong, Andrew J., Zhang, Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594418/ https://www.ncbi.nlm.nih.gov/pubmed/33115529 http://dx.doi.org/10.1186/s13045-020-00978-z

Ejemplares similares

Satraplatin in the treatment of hormone-refractory metastatic prostate cancer
por: Armstrong, Andrew J, et al.
Publicado: (2007)

First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape
por: Gulati, Shuchi, et al.
Publicado: (2022)

Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC)
por: Gupta, Eva, et al.
Publicado: (2014)

Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease
por: Harrison, Michael R, et al.
Publicado: (2013)

Pembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer
por: Tucker, Matthew D., et al.
Publicado: (2019)

Novel treatment paradigms for metastatic uveal melanoma
por: Patel, Sapna P., et al.
Publicado: (2022)

Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
por: El-Amm, Joelle, et al.
Publicado: (2013)

Changing the culture of assessment: the dominance of the summative assessment paradigm
por: Harrison, Christopher J., et al.
Publicado: (2017)

The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questions
por: Yu, Evan Y, et al.
Publicado: (2014)

Changing paradigm in advanced and metastatic non-small cell lung cancer
por: Uprety, Dipesh, et al.
Publicado: (2020)

A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer
por: Parent, Ephraim E., et al.
Publicado: (2022)

Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes
por: Laccetti, Andrew L., et al.
Publicado: (2021)

Narrative review—focal therapy: are we ready to change the prostate cancer treatment paradigm?
por: Williams, Thomas R., et al.
Publicado: (2022)

Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma
por: Tucker, Matthew D., et al.
Publicado: (2021)

Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer
por: Zhang, Tian, et al.
Publicado: (2021)

Rapidly evolving treatment paradigm and considerations for sequencing therapies in metastatic prostate cancer—a narrative review
por: Sagaram, Smitha, et al.
Publicado: (2021)

Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients
por: Holl, Eda K., et al.
Publicado: (2019)

Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab
por: Brown, Landon C., et al.
Publicado: (2021)

Pharmacodynamic study of Disulfiram in Men with Non-metastatic Recurrent Prostate Cancer
por: Schweizer, Michael T., et al.
Publicado: (2013)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
por: Shao, Zhiying, et al.
Publicado: (2016)

A new paradigm for muscle contraction
por: Herzog, Walter, et al.
Publicado: (2015)

Changing paradigms in the treatment of systemic lupus erythematosus
por: Fanouriakis, Antonis, et al.
Publicado: (2019)

Out-of-bed extubation: changing paradigms
por: Dexheimer Neto, F, et al.
Publicado: (2012)

Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
por: Borcoman, Edith, et al.
Publicado: (2021)

Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate Cancer
por: Roy, Soumyajit, et al.
Publicado: (2023)

Metastatic melanoma: New paradigms of treatment and new toxicities
por: Robert, Caroline, et al.
Publicado: (2013)

Updating the Targeted Therapy Paradigm for Patients With Metastatic NSCLC
por: Florez (DUMA), Narjust, et al.
Publicado: (2023)

Modern paradigms for prostate cancer detection and management
por: Williams, Isabella SC, et al.
Publicado: (2022)

Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer—Where Are We Now?
por: Rao, Arpit, et al.
Publicado: (2022)

Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
por: Le Tourneau, Christophe, et al.
Publicado: (2018)

Emergence of life: Physical chemistry changes the paradigm
por: Spitzer, Jan, et al.
Publicado: (2015)

Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change
por: Detti, Beatrice, et al.
Publicado: (2021)

A novel paradigm to evaluate conditioned pain modulation in fibromyalgia
por: Schoen, Cynthia J, et al.
Publicado: (2016)

Changing Paradigms in the Management of Acute Uncomplicated Diverticulitis
por: Chabok, A., et al.
Publicado: (2021)

UTR extension and alternate polyadenylation in neuroplasticity: an emerging paradigm?
por: Harrison, Benjamin J, et al.
Publicado: (2014)

Effect of Synthetic Dietary Triglycerides: A Novel Research Paradigm for Nutrigenomics
por: Sanderson, Linda M., et al.
Publicado: (2008)

Overcoming Antibiotic Resistance with Novel Paradigms of Antibiotic Selection
por: Tetz, George, et al.
Publicado: (2022)

The paradigm change in keratoconus therapy
por: Seiler, Theo
Publicado: (2013)

The pulmonary nodule: change of paradigm
por: Diederich, Stefan
Publicado: (2015)

Changing paradigm of men's health
por: Khera, Mohit
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nurpuu3f3srnsr7a37d36a3965